CDHA CAAR

November 30, 2021

CAAR – US Department of Health and Human Services, Office of Inspector General Report – November 30, 2021

Filed under: Reports and Articles — Tags: , — admin @ 5:47 pm

CMS Should Strengthen Its Prescription Drug Event Guidance To Clarify Reporting of Sponsor Margin for Medicare Part D Bids,” (A-03-17-00001, November 2021, .pdf format, 15p.).

oig.hhs.gov/oas/reports/region3/31700001.asp

November 29, 2021

CAAR – Kaiser Family Foundation Report – November 29, 2021

Filed under: Reports and Articles — Tags: , — admin @ 6:18 pm

Explaining the Prescription Drug Provisions in the Build Back Better Act,” by Juliette Cubanski, Tricia Neuman, and Meredith Freed (November 2021, .pdf and HTML format, 14p.).

www.kff.org/medicare/issue-brief/explaining-the-prescription-drug-provisions-in-the-build-back-better-act/

November 23, 2021

CAAR – Commonwealth Fund Brief – November 23, 2021

Filed under: Reports and Articles — Tags: — admin @ 5:26 pm

Brand-Name Drug Prices: The Key Driver of High Pharmaceutical Spending in the U.S.: An International Comparison of Prescription Drug Spending and Costs,” by Aimee Cicchiello and Lovisa Gustafsson (November 2021, HTML, .pdf, and Powerpoint format, 11p.).

www.commonwealthfund.org/publications/2021/nov/brand-name-drug-prices-key-driver-high-pharmaceutical-spending-in-us

September 30, 2021

CAAR – AARP Public Policy Institute Report – September 30, 2021

Filed under: Reports and Articles — Tags: — admin @ 5:39 pm

Trends in Retail Prices of Specialty Prescription Drugs Widely Used by Older Americans, 2006 to 2020,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2021, .pdf format, 30p.).

www.aarp.org/ppi/info-2019/trends-in-retail-prices-of-drugs.html

August 12, 2021

CAAR – Kaiser Family Foundation Issue Brief – August 12, 2021

Filed under: Reports and Articles — Tags: , — admin @ 5:34 pm

How Would Drug Price Negotiation Affect Medicare Part D Premiums?” by Juliette Cubanski and Tricia Neuman (August 2021, .pdf and HTML format, 3p.).

www.kff.org/medicare/issue-brief/how-would-drug-price-negotiation-affect-medicare-part-d-premiums/

 

August 4, 2021

CAAR – Public Library of Science (PLoS) Article – August 4, 2021

Filed under: Reports and Articles — Tags: , — admin @ 5:55 pm

Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016,” by Eric H. Young, Samantha Pan, Alex G. Yap, Kelly R. Reveles, and Kajal Bhakta (PLoS ONE 16(8): e0255642. doi.org/10.1371/journal.pone.0255642, XML, HTML, and .pdf format, 10p.).

journals.plos.org/plosone/article?id=10.1371/journal.pone.0255642

June 28, 2021

CAAR – AARP Public Policy Institute Report – June 28, 2021

Filed under: Reports and Articles — Tags: — admin @ 5:01 pm

Novel Anticoagulants Achieve Rapid Market Penetration despite Higher Costs,” by Catherine W. Gillespie and Leigh Purvis (June 2021, .pdf format, 7p.).

www.aarp.org/ppi/info-2021/novel-anticoagulants-achieve-rapid-market-penetration-despite-higher-costs.html

June 9, 2021

CAAR – AARP Public Policy Institute Brief, Report – June 9, 2021

Filed under: Reports and Articles — Tags: , — admin @ 6:17 pm

A. “Drug Price Increases That Exceed Inflation Are Costing Medicare Part D Billions,” by Leigh Purvis (June 2021, .pdf format, 5p.).

www.aarp.org/ppi/info-2021/drug-price-increases-that-exceed-inflation-are-costing-medicare.html

B. “Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans, 2006 to 2020,” by Leigh Purvis and Dr. Stephen Schondelmeyer (June 2021, .pdf format, p.).

www.aarp.org/ppi/info-2019/trends-in-retail-prices-of-drugs.html

May 5, 2021

CAAR – US House Committee on Energy and Commerce Hearing Testimony – May 5, 2021

Filed under: Legislation Information Updates — Tags: — admin @ 6:07 pm

Negotiating a Better Deal: Legislation to Lower the Cost of Prescription Drugs,” a hearing held May 4, 2021 (witness statements available in .pdf format, video of the full hearing available at the site, running time 4 hours 11 minutes). Note: The hearing begins at the 10:58 mark.

energycommerce.house.gov/committee-activity/hearings/hearing-on-negotiating-a-better-deal-legislation-to-lower-the-cost-of

April 28, 2021

CAAR – US Government Accountability Office Report – April 28, 2021

Filed under: Reports and Articles — Tags: — admin @ 7:01 pm

Prescription Drugs: U.S. Prices for Selected Brand Drugs Were Higher on Average than Prices in Australia, Canada, and France,” (GAO-21-282, March 2021, .pdf format, 65p.).

www.gao.gov/products/gao-21-282

April 21, 2021

CAAR – Kaiser Family Foundation Issue Brief – April 21, 2021

Filed under: Reports and Articles — Tags: , — admin @ 5:58 pm

Relatively Few Drugs Account for a Large Share of Medicare Prescription Drug Spending,” by Juliette Cubanski and Tricia Neuman (April 2021, HTML format).

www.kff.org/medicare/issue-brief/relatively-few-drugs-account-for-a-large-share-of-medicare-prescription-drug-spending/

February 19, 2021

CAAR – US Congressional Budget Office Report – February 19, 2021

Filed under: Reports and Articles — Tags: — admin @ 7:08 pm

A Comparison of Brand-Name Drug Prices Among Selected Federal Programs,” (February 2021, HTML and .pdf format, 34p.).

www.cbo.gov/publication/56978

February 8, 2021

CAAR – US Congressional Budget Office Working Paper – February 8, 2021

Filed under: Working Papers — Tags: , — admin @ 5:46 pm

CBO’s Model of Drug Price Negotiations Under the Elijah E. Cummings Lower Drug Costs Now Act,” by Christopher Adams and Evan Herrnstadt (Working Paper 2021-01, February 2021, .pdf format, 28p.). Note: A link to the abstract and the full-text of this paper is available at:

www.cbo.gov/publication/56905

February 5, 2021

CAAR – Kaiser Family Foundation Brief – February 5, 2021

Filed under: Reports and Articles — Tags: , — admin @ 5:48 pm

Price Increases Continue to Outpace Inflation for Many Medicare Part D Drugs,” by Juliette Cubanski and Tricia Neuman (February 2021, HTML format).

www.kff.org/medicare/issue-brief/price-increases-continue-to-outpace-inflation-for-many-medicare-part-d-drugs/

January 28, 2021

CAAR – Public Library of Science (PLoS) Article – January 28, 2021

A. “Association of low back pain with muscle weakness, decreased mobility function, and malnutrition in older women: A cross-sectional study,” by Satoshi Kato, Satoru Demura, Kazuya Shinmura, Noriaki Yokogawa, Tamon Kabata, Hidenori Matsubara, Yoshitomo Kajino, Kentaro Igarashi, Daisuke Inoue, Yuki Kurokawa, Norihiro Oku, and Hiroyuki Tsuchiya (PLoS ONE 16(1): e0245879. doi.org/10.1371/journal.pone.0245879, HTML, XML, and .pdf format, 11p.).

journals.plos.org/plosone/article?id=10.1371/journal.pone.0245879

B. “Adipocyte-induced transdifferentiation of osteoblasts and its potential role in age-related bone loss,” by Aline Clabaut, Céline Grare, Gaëlle Rolland-Valognes, Jean-Guillaume Letarouilly, Chantal Bourrier, Thomas L. Andersen, Tanja Sikjær, Lars Rejnmark, Charlotte Ejersted, Philippe Pastoureau, Pierre Hardouin, Massimo Sabatini, and Odile Broux (PLoS ONE 16(1): e0245014. doi.org/10.1371/journal.pone.0245014, HTML, XML, and .pdf format, 17p.).

journals.plos.org/plosone/article?id=10.1371/journal.pone.0245014

C. “Identification of drug combinations on the basis of machine learning to maximize anti-aging effects,” by Sun Kyung Kim, Peter C. Goughnour, Eui Jin Lee, Myeong Hyun Kim, Hee Jin Chae, Gwang Yeul Yun, Yi Rang Kim, and Jin Woo Choi (PLoS ONE 16(1): e0246106. doi.org/10.1371/journal.pone.0246106, XML, HTML, and .pdf format, 19p.).

journals.plos.org/plosone/article?id=10.1371/journal.pone.0246106

January 14, 2021

CAAR – US Government Accountability Office Report – January 14, 2021

Filed under: Reports and Articles — Tags: , — admin @ 7:31 pm

Prescription Drugs: Department of Veterans Affairs Paid About Half as Much as Medicare Part D for Selected Drugs in 2017,” (GAO-21-111, December 2020, .pdf format, 23p.).

www.gao.gov/products/GAO-21-111

December 29, 2020

CAAR – US Agency for Healthcare Research and Quality Brief – December 29, 2020

Filed under: Reports and Articles — Tags: — admin @ 5:42 pm

Out-of-Pocket Spending for Retail Prescribed Drugs by Age and Type of Prescription Drug Coverage, 2009 to 2018,” by William A. Carroll, G. Edward Carroll, and Steven C. Hill (Medical Expenditure Panel Survey Statistical Brief No. 532, December 2020, .pdf and HTML format, 11p.).

meps.ahrq.gov/mepsweb/data_stats/Pub_ProdResults_Details.jsp?pt=Statistical+Brief&opt=2&id=1271

October 29, 2020

CAAR – Kaiser Family Foundation Issue Brief – October 29, 2020

Filed under: Reports and Articles — Tags: , — admin @ 6:14 pm

Medicare Part D: A First Look at Medicare Prescription Drug Plans in 2021,” by Juliette Cubanski and Anthony Damico (October 2020, HTML format).

www.kff.org/medicare/issue-brief/medicare-part-d-a-first-look-at-medicare-prescription-drug-plans-in-2021/

August 20, 2020

CAAR – Kaiser Family Foundation Issue Brief – August 20, 2020

Filed under: Reports and Articles — Tags: , , — admin @ 6:00 pm

Mail Delays Could Affect Mail-Order Prescriptions for Millions of Medicare Part D and Large Employer Plan Enrollees,” by Juliette Cubanski, Jeannie Fuglesten Biniek, Matthew Rae, Anthony Damico, Brittni Frederiksen, and Alina Salganicoff (August 2020, HTML format).

www.kff.org/coronavirus-covid-19/issue-brief/mail-delays-could-affect-mail-order-prescriptions-for-millions-of-medicare-part-d-and-large-employer-plan-enrollees/

July 9, 2020

CAAR – US Department of Health and Human Service, Office of Inspector General Report – July 9, 2020

Filed under: Reports and Articles — Tags: , — admin @ 8:21 pm

Loophole in Drug Payment Rule Continues To Cost Medicare and Beneficiaries Hundreds of Millions of Dollars,” (OEI-BL-20-00100, July 2020, .pdf format, 16p.).

oig.hhs.gov/oei/reports/OEI-BL-20-00100.asp

April 14, 2020

CAAR – US Government Accountability Office Report – April 14, 2020

Filed under: Reports and Articles — Tags: , — admin @ 7:56 pm

Preventing Drug Diversion: Disposal of Controlled Substances in Home Hospice Settings,” (GAO-20-378, April 2020, .pdf format, 21p.).

www.gao.gov/products/GAO-20-378

April 13, 2020

CAAR – Commonwealth Fund Issue Brief – April 13, 2020

Filed under: Reports and Articles — Tags: — admin @ 5:19 pm

The Elijah E. Cummings Lower Drug Costs Now Act: How It Would Work, How It Would Affect Prices, and What the Challenges Are,” by Paul B. Ginsburg and Steven M. Lieberman (April 2020, .pdf and HTML format, 8p.).

www.commonwealthfund.org/publications/issue-briefs/2020/apr/lower-drug-costs-now-act-hr3-how-it-would-work

March 23, 2020

CAAR – Kaiser Family Foundation Issue Brief – March 23, 2020

Filed under: Reports and Articles — Tags: , — admin @ 4:37 pm

Examining Current Medicare Part D Policies for Extended Supplies of Medication,” by Juliette Cubanski, Karyn Schwartz, and Anthony Damico (March 2020, HTML format).

www.kff.org/medicare/issue-brief/examining-current-medicare-part-d-policies-for-extended-supplies-of-medication/

November 27, 2019

CAAR – Kaiser Family Foundation Issue Brief – November 27, 2019

Filed under: Reports and Articles — Tags: , — admin @ 4:36 pm

A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries,” by Meredith Freed, Juliette Cubanski, and Tricia Neuman (November 2019, .pdf and HTML format, 27p.).

www.kff.org/medicare/issue-brief/a-look-at-recent-proposals-to-control-drug-spending-by-medicare-and-its-beneficiaries/

October 23, 2019

CAAR – Kaiser Family Foundation Brief – October 23, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:07 pm

Assessing Drug Price Increases in Medicare Part D and the Implications of Inflation Limits,” by Juliette Cubanski and Tricia Neuman (October 2019, .pdf format, 6p.).

www.kff.org/medicare/issue-brief/assessing-drug-price-increases-in-medicare-part-d-and-the-implications-of-inflation-limits/

October 1, 2019

CAAR – Commonwealth Fund Chart – October 1, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:36 pm

Key Provisions of Proposals on Drug Price Negotiation, Inflation Rebates, and Medicare Part D Redesign,” (September 2019, .pdf and HTML format, 2p.).

www.commonwealthfund.org/publications/2019/sep/key-provisions-proposals-drug-price-negotiation-inflation-rebates-part-d-redesign

September 27, 2019

CAAR – US House Committee on Energy and Commerce Hearing Testimony – September 27, 2019

Filed under: Legislation Information Updates — Tags: — admin @ 4:35 pm

Making Prescription Drugs More Affordable: Legislation to Negotiate a Better Deal for Americans,” a hearing held September 25, 2019 (witness statements available in .pdf format, video available at the site, running time 4 hours 23 minutes). Note: Hearing starts at the 10:15 mark.

energycommerce.house.gov/committee-activity/hearings/hearing-on-making-prescription-drugs-more-affordable-legislation-to

CAAR – Center for Retirement Research at Boston College Issue Brief – September 27, 2019

Filed under: Reports and Articles — Tags: , — admin @ 4:30 pm

Medicare Part D’s Effect on Evergreening, Generics, and Drug Prices,” by Geoffrey T. Sanzenbacher and Gal Wettstein (IB No. 19-14, September 2019, .pdf and Excel format, 7p.).

crr.bc.edu/briefs/medicare-part-ds-effect-on-evergreening-generics-and-drug-prices/

September 26, 2019

CAAR – AARP Public Policy Institute Report – September 26, 2019

Filed under: Reports and Articles — Tags: — admin @ 5:01 pm

Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2017 Year-End Update,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2019, .pdf format, 17p.).

www.aarp.org/ppi/info-2019/trends-in-retail-prices-of-drugs.html

August 22, 2019

CAAR – Australia Institute of Health and Welfare Reports – August 22, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:37 pm

A. “Hospital care for people with dementia 2016–17,” (August 2019, .pdf format, 17p.).

www.aihw.gov.au/reports/dementia/hospital-care-for-people-with-dementia-2016-17/contents/table-of-contents

B. “Dispensing patterns for anti-dementia medications 2016–17,” (August 2019, .pdf format, 23p.).

www.aihw.gov.au/reports/dementia/dispensing-patterns-for-anti-dementia-medications/contents/table-of-contents

August 19, 2019

CAAR – US Department of Health and Human Services, Office of Inspector General Report – August 19, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:45 pm

Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2017 Average Sales Prices,” (OEI-03-19-00260, August 2019, .pdf format, 12p.).

oig.hhs.gov/oei/reports/oei-03-19-00260.asp

August 15, 2019

CAAR – US National Center for Health Statistics Data Brief – August 15, 2019

Filed under: Reports and Articles — Tags: — admin @ 5:34 pm

Prescription Drug Use Among Adults Aged 40–79 in the United States and Canada,” by Craig M. Hales, Jennifer Servais, Crescent B. Martin, and Dafna Kohen (Data Brief No. 347, August 2019, HTML and .pdf format, 8p.).

www.cdc.gov/nchs/products/databriefs/db347.htm

August 2, 2019

CAAR – Kaiser Family Foundation Issue Brief – August 2, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:00 pm

A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries,” by Meredith Freed, Juliette Cubanski, and Tricia Neuman (August 2019, HTML and .pdf format, 27p.).

www.kff.org/medicare/issue-brief/a-look-at-recent-proposals-to-control-drug-spending-by-medicare-and-its-beneficiaries/

June 27, 2019

CAAR – AARP Public Policy Institute Report – June 27, 2019

Filed under: Reports and Articles — Tags: — admin @ 4:01 pm

Rx Price Watch Report: Trends in Retail Prices of Specialty Prescription Drugs Widely Used by Older Americans, 2017 Year-End Update,” by Leigh Purvis and Dr. Stephen Schondelmeyer (June 2019, .pdf format, 25p.).

www.aarp.org/ppi/info-2019/trends-in-retail-prices-of-drugs.html?INTCMP=RDRCT-PPI-HEALTH-040919

June 25, 2019

CAAR – Kaiser Family Foundation Issue Brief – June 25, 2019

Filed under: Reports and Articles — Tags: , — admin @ 4:55 pm

How Many Medicare Part D Enrollees Had High Out-of-Pocket Drug Costs in 2017?” by Juliette Cubanski, Tricia Neuman, and Anthony Damico (June 2019, .pdf format, 12p.).

www.kff.org/medicare/issue-brief/how-many-medicare-part-d-enrollees-had-high-out-of-pocket-drug-costs-in-2017/

June 19, 2019

CAAR – US Senate Special Committee on Aging Committee Hearing – June 19, 2019

Filed under: Legislation Information Updates — Tags: — admin @ 4:48 pm

The Complex Web of Prescription Drug Prices, Part III: Examining Agency Efforts to Further Competition and Increase Affordability,” a hearing held June 19, 2019 (witness statements available in .pdf format, video of the full hearing available at the site, running time 1 hour 41 minutes). Note: The hearing begins at the 13:43 mark.

www.aging.senate.gov/hearings/the-complex-web-of-prescription-drug-prices-part-iii-examining-agency-efforts-to-further-competition-and-increase-affordability

 

May 30, 2019

CAAR – Center for Retirement Research at Boston College Working Paper – May 30, 2019

Filed under: Reports and Articles — Tags: , — admin @ 4:50 pm

The Effect of Medicare Part D on Evergreening, Generic Entry, and Drug Prices,” by Geoffrey T. Sanzenbacher and Gal Wettstein (WP No.2019-8, May 2019, .pdf and Excel format, 24p.). Note: Links to the abstract and the full text of this paper available at:

crr.bc.edu/working-papers/the-effect-of-medicare-part-d-on-evergreening-generic-entry-and-drug-prices/

May 29, 2019

CAAR – Journal of the American Medical Association Article Abstract – May 29, 2019

Filed under: Reports and Articles — Tags: , , — admin @ 5:34 pm

Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019,” by Stacie B. Dusetzina, Haiden A. Huskamp, and Nancy L. Keating (Vol. 321, No. 20, May 28, 2019, p. 2025-2027).

jamanetwork.com/journals/jama/article-abstract/2734308

May 23, 2019

CAAR – US National Center for Health Statistics Brief, Report – May 23, 2019

Filed under: Reports and Articles — Tags: , , , , — admin @ 5:47 pm

A. “Strategies Used by Adults Aged 65 and Over to Reduce Their Prescription Drug Costs, 2016–2017,” by Robin A. Cohen and Peter Boersma (NCHS Data Brief No. 335, May 2019, .pdf and HTML format, 7p.).

www.cdc.gov/nchs/products/databriefs/db335.htm

B. “Trends in Cancer and Heart Disease Death Rates Among Adults Aged 45–64: United States, 1999–2017,” by Sally C. Curtin (National Vital Statistics Report, Vol. 68, No. 5, May 2019, .pdf format, 8p.).

www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_05-508.pdf

May 1, 2019

CAAR – US House Committee on Energy and Commerce, Subcommittee on Health Hearing Testimony – May 1, 2019

Filed under: Legislation Information Updates — Tags: , — admin @ 5:38 pm

Prescription Drug Coverage in the Medicare Program,” a hearing held April 30, 2019 (witness statements available in .pdf format, video of the full hearing available at the site, running time 2 hours 9 minutes). Note: Hearing starts at the 11:10 mark, and ends at the 2:23:50 mark.

energycommerce.house.gov/committee-activity/hearings/hearing-on-prescription-drug-coverage-in-the-medicare-program

April 8, 2019

CAAR – AARP Public Policy Institute Report – April 8, 2019

Filed under: Reports and Articles — Tags: — admin @ 4:53 pm

Rx Price Watch Report: Trends in Retail Prices of Generic Prescription Drugs Widely Used by Older Americans: 2017 Year-End Update,” by Leigh Purvis, and Dr. Stephen Schondelmeyer (April 2019, .pdf format, 23p.).

www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html

March 21, 2019

CAAR – AARP Public Policy Institute Report – March 21, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:51 pm

Specialty Drugs in Breast Cancer: Health Care Utilization and Costs in the First Year after Diagnosis,” by Elizabeth Carter and Leigh Purvis (March 2019, .pdf format, 4p.).

www.aarp.org/ppi/info-2019/specialty-drugs-in-breast-cancer-health-care-utilization.html

March 20, 2019

CAAR – Congressional Budget Office Working Paper – March 20, 2019

Filed under: Working Papers — Tags: , , — admin @ 5:18 pm

Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid: An In-Depth Analysis,” by Anna Anderson-Cook, Jared Maeda, and Lyle Nelson (Working Paper 2019-02, March 2019, .pdf format, 58p.). Note: Links to the abstract and the full text of the paper available at:

www.cbo.gov/publication/55011

March 7, 2019

CAAR – US House Committee on Ways and Means, Subcommittee on Health Hearing Testimony – March 7, 2019

Filed under: Legislation Information Updates — Tags: , — admin @ 4:56 pm

Promoting Competition to Lower Medicare Drug Prices,” a hearing held March 7, 2019 (witness statements available in .pdf format).

waysandmeans.house.gov/legislation/hearings/promoting-competition-lower-medicare-drug-prices

Video of the full hearing available at (running time 2 hours 19 minutes):

www.youtube.com/c/waysandmeanscommitteehearings

CAAR – US Senate Special Committee on Aging Hearing Testimony – March 7, 2019

Filed under: Legislation Information Updates — Tags: — admin @ 4:52 pm

A. “The Complex Web of Prescription Drug Prices, Part I: Patients Struggling with Rising Costs,” a hearing held March 6, 2019 (witness statements available in .pdf format, video of the full hearing available on the site, running time 1 hour 56 minutes). Note: The hearing begins at the 16:04 mark.

www.aging.senate.gov/hearings/the-complex-web-of-prescription-drug-prices-part-i-patients-struggling-with-rising-costs

B. “The Complex Web of Prescription Drug Prices, Part II: Untangling the Web and Paths Forward,” a hearing held March 7, 2019 (witness statements available in .pdf format, video of the full hearing available on the site, running time 1 hour 32 minutes). Note: The hearing begins at the 17:19 mark.

www.aging.senate.gov/hearings/the-complex-web-of-prescription-drug-prices-part-ii-untangling-the-web-and-paths-forward

February 1, 2019

CAAR – National Bureau of Economic Research Working Papers – February 1, 2019

Links to an abstract are available. For full text availability check your organization’s library.

A. “How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013,” by Frank R. Lichtenberg (w25483, January 2019, .pdf format, 23p.).

www.nber.org/papers/w25483

B. “The Impact of a Wartime Health Shock on the Postwar Socioeconomic Status and Mortality of Union Army Veterans and their Children,” by Dora Costa, Noelle Yetter, and Heather DeSomer (w25480, January 2019, .pdf format, 47p.).

www.nber.org/papers/w25480

C. “Is There a Demand for Reverse Mortgages in China? Evidence from Two Online Surveys,” by Katja Hanewald, Hazel Bateman, Hanming Fang, and Shang Wu (w25491, January 2019, .pdf format, 35p.).

www.nber.org/papers/w25491

CAAR – Kaiser Family Foundation Issue Brief – February 1, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:10 pm

The Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019,” by Juliette Cubanski, Wyatt Koma, and Tricia Neuman (January 2019, .pdf and HTML format, 16p.).

www.kff.org/medicare/issue-brief/the-out-of-pocket-cost-burden-for-specialty-drugs-in-medicare-part-d-in-2019/

January 2, 2019

CAAR – Commonwealth Fund Blog – January 2, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:20 pm

Proposed Changes to Medicare Part D Would Benefit Drug Manufacturers More Than Beneficiaries,” by Shawn Bishop (January 2019).

www.commonwealthfund.org/blog/2019/proposed-changes-medicare-part-d-would-benefit-drug-manufacturers-more-beneficiaries

November 13, 2018

CAAR – Journal of the American Medical Association Article Abstract – November 13, 2018

Filed under: Reports and Articles — Tags: , — admin @ 4:41 pm

Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial,” by Philippe Martin, Robyn Tamblyn, Andrea Benedetti, Sara Ahmed, and Cara Tannenbaum (Vol. 320, No. 18, November 13, 2018, p. 1889-1898).

jamanetwork.com/journals/jama/article-abstract/2714531

 

September 27, 2018

CAAR – AARP Public Policy Institute Report – September 27, 2018

Filed under: Reports and Articles — Tags: — admin @ 5:21 pm

Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2017 Year-End Update,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2018, .pdf format, 24p.).

www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html

Older Posts »

Powered by WordPress